FDA 483 - Naturavit Inc - April 07, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Naturavit Inc, a dietary supplements own label distributor in Miami, FL, revealed significant deficiencies in their manufacturing and quality control processes. The firm failed to establish product specifications for finished dietary supplements, did not ensure components met specifications through testing or certificates of analysis, and did not follow its own written procedures for vendor qualification and labeling operations. Several of these issues were repeat observations from previous FDA inspections, indicating a persistent lack of compliance.
ID · 05861494-4741-439f-8f21-3603dd343a02